Cargando…
Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a highly immunogenic tumor. The purpose of the present study was to establish a novel immunotype for different immune infiltration and overall survival (OS) of patients with ccRCC. METHODS: Based on the Cancer Genome Atlas Project (TCGA) databas...
Autores principales: | Yu, Deshui, Zhang, Xuanzhi, Gao, Lixia, Qian, Subo, Tang, Hong, Shao, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552763/ https://www.ncbi.nlm.nih.gov/pubmed/36237315 http://dx.doi.org/10.3389/fonc.2022.924072 |
Ejemplares similares
-
Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma
por: Li, Wei, et al.
Publicado: (2019) -
A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients
por: Zhao, Yiqiao, et al.
Publicado: (2020) -
Identification of a Risk Stratification Model to Predict Overall Survival and Surgical Benefit in Clear Cell Renal Cell Carcinoma With Distant Metastasis
por: Chen, Jiasheng, et al.
Publicado: (2021) -
Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022) -
Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)